Immunological Activity of Chondroitin Sulfate

Loading...
Thumbnail Image
Authors
Toida, Toshihiko
Sakai, Shinobu
Akiyama, Hiroshi
Linhardt, Robert J.
Issue Date
2006-12-01
Type
Book chapter
Language
ENG
Keywords
Biology , Chemistry and chemical biology , Chemical and biological engineering , Biomedical engineering
Research Projects
Organizational Units
Journal Issue
Alternative Title
Abstract
The use of chondroitin sulfate (CS) for the symptomatic treatment of osteoarthritis (OA) has become very popular; however, it has also been the subject of controversy for several reasons. First, the nutraceutical industry is less regulated than the pharmaceutical industry and thus, the nutraceutical CS often suffers from poor quality control. Second, the bioavailability of orally administered CS is not generally accepted. Third, the mechanism of the effect of CS for treatment of OA remains unclear. There is abundant in vitro and in vivo evidence from animal and human clinical studies demonstrating the efficacy and safety of CS. This chapter focuses on the immunological activity of structurally regulated CSs. The mechanism of this immunological activity appears to be through CS binding to receptors related to cytokine production in lymphocytes such as splenocytes.
Description
Chondroitin Sulfate Structure, Role and Pharmacological Activity-Advances in Pharmacology, N. Volpi Ed., Elsevier, Chapter 19
Note : if this item contains full text it may be a preprint, author manuscript, or a Gold OA copy that permits redistribution with a license such as CC BY. The final version is available through the publisher’s platform.
Full Citation
Immunological Activity of Chondroitin Sulfate, T. Toida, S. Sakai, H. Akiyama, R. J. Linhardt, Chondroitin Sulfate Structure, Role and Pharmacological Activity-Advances in Pharmacology, N. Volpi Ed., Elsevier, Chapter 19, 2006.
Publisher
Elsevier
Terms of Use
Journal
Volume
Issue
PubMed ID
DOI
ISSN
10543589
EISSN